Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
09/05/2025
Trump: If Mattel's performance exceeds that of the United States, I will put 100% of my stake on toys.
Latest
3 m ago
Statement shows: Detroit's three major automotive trade groups state that the trade agreement between Trump and the UK "damages the interests of American auto manufacturers, suppliers, and automotive workers."
6 m ago
Marathon Digital Holdings (MARA.US): The 2025 Q1 financial report achieved revenue of 2.139 billion US dollars, with the previous value being 1.652 billion US dollars, and the expected value being 2.321 billion US dollars; earnings per share were -1.55 US dollars, with the previous value being 1.26 US dollars, and the expected value being 0.57 US dollars.
6 m ago
ICU Medical (ICUI.US): In the first quarter of 2025, revenue reached $604.7 million, up from $566.7 million in the previous quarter and surpassing the expected value of $574.2 million. Earnings per share were $1.72, higher than the previous quarter's $0.96 and beating the expected value of $1.28.
6 m ago
Lisata Therapeutics (LSTA.US): The first quarter financial report for 2025 shows an earnings per share of -$0.55, compared to the previous value of -$0.65 and an expected value of -$0.53.
6 m ago
Theravance Biopharma (TBPH.US) financial report for Q1 2025 shows revenue of $15.388 million, compared to the previous value of $14.503 million and an expected value of $28.07 million; earnings per share were -$0.27, compared to the previous value of -$0.09 and an expected value of -$0.09.
See all latest
